377 related articles for article (PubMed ID: 24911152)
1. Missense dopamine transporter mutations associate with adult parkinsonism and ADHD.
Hansen FH; Skjørringe T; Yasmeen S; Arends NV; Sahai MA; Erreger K; Andreassen TF; Holy M; Hamilton PJ; Neergheen V; Karlsborg M; Newman AH; Pope S; Heales SJ; Friberg L; Law I; Pinborg LH; Sitte HH; Loland C; Shi L; Weinstein H; Galli A; Hjermind LE; Møller LB; Gether U
J Clin Invest; 2014 Jul; 124(7):3107-20. PubMed ID: 24911152
[TBL] [Abstract][Full Text] [Related]
2. Identifying dominant-negative actions of a dopamine transporter variant in patients with parkinsonism and neuropsychiatric disease.
Herborg F; Jensen KL; Tolstoy S; Arends NV; Posselt LP; Shekar A; Aguilar JI; Lund VK; Erreger K; Rickhag M; Lycas MD; Lonsdale MN; Rahbek-Clemmensen T; Sørensen AT; Newman AH; Løkkegaard A; Kjærulff O; Werge T; ; Møller LB; Matthies HJ; Galli A; Hjermind LE; Gether U
JCI Insight; 2021 Sep; 6(18):. PubMed ID: 34375312
[TBL] [Abstract][Full Text] [Related]
3. Neuropsychiatric disease-associated genetic variants of the dopamine transporter display heterogeneous molecular phenotypes.
Herborg F; Andreassen TF; Berlin F; Loland CJ; Gether U
J Biol Chem; 2018 May; 293(19):7250-7262. PubMed ID: 29559554
[TBL] [Abstract][Full Text] [Related]
4. Homozygous loss-of-function mutations in the gene encoding the dopamine transporter are associated with infantile parkinsonism-dystonia.
Kurian MA; Zhen J; Cheng SY; Li Y; Mordekar SR; Jardine P; Morgan NV; Meyer E; Tee L; Pasha S; Wassmer E; Heales SJ; Gissen P; Reith ME; Maher ER
J Clin Invest; 2009 Jun; 119(6):1595-603. PubMed ID: 19478460
[TBL] [Abstract][Full Text] [Related]
5. SPECT and PET of the dopamine transporter in attention-deficit/hyperactivity disorder.
Krause J
Expert Rev Neurother; 2008 Apr; 8(4):611-25. PubMed ID: 18416663
[TBL] [Abstract][Full Text] [Related]
6. Single Quantum Dot Imaging Reveals PKCβ-Dependent Alterations in Membrane Diffusion and Clustering of an Attention-Deficit Hyperactivity Disorder/Autism/Bipolar Disorder-Associated Dopamine Transporter Variant.
Thal LB; Tomlinson ID; Quinlan MA; Kovtun O; Blakely RD; Rosenthal SJ
ACS Chem Neurosci; 2019 Jan; 10(1):460-471. PubMed ID: 30153408
[TBL] [Abstract][Full Text] [Related]
7. ADHD and the dopamine transporter: are there reasons to pay attention?
Mazei-Robinson MS; Blakely RD
Handb Exp Pharmacol; 2006; (175):373-415. PubMed ID: 16722244
[TBL] [Abstract][Full Text] [Related]
8. Attention deficit/hyperactivity disorder-derived coding variation in the dopamine transporter disrupts microdomain targeting and trafficking regulation.
Sakrikar D; Mazei-Robison MS; Mergy MA; Richtand NW; Han Q; Hamilton PJ; Bowton E; Galli A; Veenstra-Vanderweele J; Gill M; Blakely RD
J Neurosci; 2012 Apr; 32(16):5385-97. PubMed ID: 22514303
[TBL] [Abstract][Full Text] [Related]
9. Infantile parkinsonism-dystonia: a dopamine "transportopathy".
Blackstone C
J Clin Invest; 2009 Jun; 119(6):1455-8. PubMed ID: 19504720
[TBL] [Abstract][Full Text] [Related]
10. Methylphenidate DAT binding in adolescents with Attention-Deficit/ Hyperactivity Disorder comorbid with Substance Use Disorder--a single photon emission computed tomography with [Tc(99m)]TRODAT-1 study.
Szobot CM; Shih MC; Schaefer T; Júnior N; Hoexter MQ; Fu YK; Pechansky F; Bressan RA; Rohde LA
Neuroimage; 2008 Apr; 40(3):1195-201. PubMed ID: 18282769
[TBL] [Abstract][Full Text] [Related]
11. Single-quantum-dot tracking reveals altered membrane dynamics of an attention-deficit/hyperactivity-disorder-derived dopamine transporter coding variant.
Kovtun O; Sakrikar D; Tomlinson ID; Chang JC; Arzeta-Ferrer X; Blakely RD; Rosenthal SJ
ACS Chem Neurosci; 2015 Apr; 6(4):526-34. PubMed ID: 25747272
[TBL] [Abstract][Full Text] [Related]
12. Is dopamine transporter-mediated dopaminergic signaling in the retina a noninvasive biomarker for attention-deficit/ hyperactivity disorder? A study in a novel dopamine transporter variant Val559 transgenic mouse model.
Dai H; Jackson CR; Davis GL; Blakely RD; McMahon DG
J Neurodev Disord; 2017 Dec; 9(1):38. PubMed ID: 29281965
[TBL] [Abstract][Full Text] [Related]
13. Dual Action of Zn2+ on the Transport Cycle of the Dopamine Transporter.
Li Y; Hasenhuetl PS; Schicker K; Sitte HH; Freissmuth M; Sandtner W
J Biol Chem; 2015 Dec; 290(52):31069-76. PubMed ID: 26504078
[TBL] [Abstract][Full Text] [Related]
14. Novel ATP13A2 (PARK9) homozygous mutation in a family with marked phenotype variability.
Santoro L; Breedveld GJ; Manganelli F; Iodice R; Pisciotta C; Nolano M; Punzo F; Quarantelli M; Pappatà S; Di Fonzo A; Oostra BA; Bonifati V
Neurogenetics; 2011 Feb; 12(1):33-9. PubMed ID: 20853184
[TBL] [Abstract][Full Text] [Related]
15. Attention deficit hyperactivity disorder: binding of [99mTc]TRODAT-1 to the dopamine transporter before and after methylphenidate treatment.
Dresel S; Krause J; Krause KH; LaFougere C; Brinkbäumer K; Kung HF; Hahn K; Tatsch K
Eur J Nucl Med; 2000 Oct; 27(10):1518-24. PubMed ID: 11083541
[TBL] [Abstract][Full Text] [Related]
16. Dopamine transporter deficiency syndrome: phenotypic spectrum from infancy to adulthood.
Ng J; Zhen J; Meyer E; Erreger K; Li Y; Kakar N; Ahmad J; Thiele H; Kubisch C; Rider NL; Morton DH; Strauss KA; Puffenberger EG; D'Agnano D; Anikster Y; Carducci C; Hyland K; Rotstein M; Leuzzi V; Borck G; Reith ME; Kurian MA
Brain; 2014 Apr; 137(Pt 4):1107-19. PubMed ID: 24613933
[TBL] [Abstract][Full Text] [Related]
17. Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity.
Jucaite A; Fernell E; Halldin C; Forssberg H; Farde L
Biol Psychiatry; 2005 Feb; 57(3):229-38. PubMed ID: 15691523
[TBL] [Abstract][Full Text] [Related]
18. Genetic imaging study with [Tc-
Akay AP; Kaya GÇ; Kose S; Yazıcıoğlu ÇE; Erkuran HÖ; Güney SA; Oğuz K; Keskin D; Baykara B; Emiroğlu Nİ; Eren MŞ; Kızıldağ S; Ertay T; Özsoylu D; Miral S; Durak H; Gönül AS; Rohde LA
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Aug; 86():294-300. PubMed ID: 29684537
[TBL] [Abstract][Full Text] [Related]
19. Dopamine transporter density measured by [123I]beta-CIT single-photon emission computed tomography is normal in dopa-responsive dystonia.
Jeon BS; Jeong JM; Park SS; Kim JM; Chang YS; Song HC; Kim KM; Yoon KY; Lee MC; Lee SB
Ann Neurol; 1998 Jun; 43(6):792-800. PubMed ID: 9629849
[TBL] [Abstract][Full Text] [Related]
20.
Yang HJ; Park SH; Seo M; Weon YC; Kim Y
Neurotoxicology; 2018 Jan; 64():78-84. PubMed ID: 28259768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
